INTEREST

Treatment as Prevention (TasP) studies: the challenge of CD4 count treatment eligibility changes in Africa. Perspectives from the TasP ANRS 12249 trial

Communications Wednesday 6 May 2015

Oral communication presented at the 9^th INTEREST Workshop in Harare the 7^th of May 2015 in session Round table: Treatment as Prevention (TaSP) studies.

Dr Joseph Larmarange from on Vimeo.

Reference

Larmarange Joseph (2015) “Treatment as Prevention (TasP) studies: the challenge of CD4 count treatment eligibility changes in Africa. Perspectives from the TasP ANRS 12249 trial” (communication orale), presented at the 9th INTEREST Workshop, Harare. http://www.virology-education.com/online-program-9th-interest/.